Participant with MSDBP ≥ 110mmHg or MSSBP ≥ 180mmHg.
Participant currently taking ≥ 2 antihypertensive medications (note: fixed-dose combination medicine should be counted as the number of active ingredients).
Participant with known secondary hypertension of any etiology.
Participant with malignant hypertension or current evidence of impending or active malignant hypertension, including headache, papilledema, cardiac ischemia, or pulmonary congestion precipitated by elevated blood pressure.
Participant with known intolerance, contraindication or hypersensitivity to any component of dihydropyridines, angiotensin II receptor blockers.
Participant showing positive in pregnancy test, lactating woman, or woman who intends to get pregnant during the study period.
